(Q44587943)

English

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets (English)

1 reference

Europe PubMed Central

4 December 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Charles F. Levenback

7

object named as

Charles F Levenback

1 reference

Europe PubMed Central

4 December 2017

author name string

Lois M Ramondetta

1

1 reference

Europe PubMed Central

4 December 2017

Thomas W Burke

2

1 reference

Europe PubMed Central

4 December 2017

Anuja Jhingran

3

1 reference

Europe PubMed Central

4 December 2017

Rosemarie Schmandt

4

1 reference

Europe PubMed Central

4 December 2017

Michael W Bevers

5

1 reference

Europe PubMed Central

4 December 2017

Judith K Wolf

6

1 reference

Europe PubMed Central

4 December 2017

Russell Broaddus

8

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

4 December 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

4 December 2017

90

1 reference

Europe PubMed Central

4 December 2017

3

1 reference

Europe PubMed Central

4 December 2017

529-536

1 reference

Europe PubMed Central

4 December 2017

The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed mesodermal sarcoma of the uterus.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of recurrence in malignant mixed müllerian tumor of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine carcinosarcomas: incidence and trends in management and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy in the treatment of uterine sarcomas. A retrospective analysis of 54 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of uterine sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Català-Occità

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant therapy for stage I uterine sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of uterine papillary serous carcinoma with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational therapeutic intervention in cancer: kinases as drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900332-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-8258(03)00332-9

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44587943&oldid=2028781785"